In early September 2019, Johns Hopkins opened its new Center for Psychedelic and Consciousness Research, which explores the use of psychedelics on brain function, memory, and the brain’s biology.
The center explores the use of psilocybin in patients with opioid addiction, Alzheimer’s disease, post-traumatic stress disorder, and other neurologic conditions. This research is reflective of a “new era of research in therapeutics and the mind,” as the center’s director, Ronald Griffiths, PhD, describes.
The center was started from a donation of $17 million from a group of private donors, and for the first 5 years, several philanthropists (including Matt Mullenweg, the co-founder of WordPress, and Blake Mycoskie, the founder of TOMS shoes) will privately fund the center’s operating costs.
The center’s research into this innovative treatment paradigm may open the door for healthcare providers in their efforts to care for patients with various neurologic conditions.
Please read more about the center here.
Source:
